Novavax (NVAX) Reports Selling 10M Common at $1.22/Share
Novavax, Inc. (Nasdaq: NVAX) announced today that on Friday, May 18, 2012, it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund, LP at a price of $1.22 per share. The shares were offered under an effective shelf registration statement previously filed with the Securities and Exchange Commission.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FXCM, Inc. (FXCM) Board Adopts 'Poison Pill' Provision
- Advanced Emissions Solutions (ADES) Independent Account Firm KPMG Resigns
- Doral Financial (DRL) Reports Modification to FHLB Facility; FDIC Issues Prompt Corrective Action Directive
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!